Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Johnson and Johnson
Harvard Business School

Generated: February 20, 2019

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 206891

« Back to Dashboard

NDA 206891 describes HYDROCODONE BITARTRATE AND CHLORPHENIRAMINE MALEATE, which is a drug marketed by Acella Pharms Llc and Tris Pharma Inc and is included in two NDAs. It is available from one supplier. Additional details are available on the HYDROCODONE BITARTRATE AND CHLORPHENIRAMINE MALEATE profile page.

The generic ingredient in HYDROCODONE BITARTRATE AND CHLORPHENIRAMINE MALEATE is chlorpheniramine maleate; hydrocodone bitartrate. There are twenty-nine drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the chlorpheniramine maleate; hydrocodone bitartrate profile page.
Pharmacology for NDA: 206891
Suppliers and Packaging for NDA: 206891
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
HYDROCODONE BITARTRATE AND CHLORPHENIRAMINE MALEATE chlorpheniramine maleate; hydrocodone bitartrate SOLUTION;ORAL 206891 ANDA Acella Pharmaceuticals, LLC 42192-612 42192-612-16 480 mL in 1 BOTTLE (42192-612-16)

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:SOLUTION;ORALStrength4MG/5ML;5MG/5ML
Approval Date:Jun 9, 2017TE:AARLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Chinese Patent Office
Johnson and Johnson
US Department of Justice

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.